UB Paderborn / Katalog / Suche / in CDI

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL

Annals of oncology, 2021-04, Vol.32 (4), p.488-499

2021

Volltextzugriff (PDF)

Port-a-Cath® extravasation of vesicant cytotoxics: Surgical options for a rare complication of cancer chemotherapy

European journal of surgical oncology, 2015-03, Vol.41 (3), p.378-385

2015

Volltextzugriff (PDF)

New perspectives in stem cell research: beyond embryonic stem cells

Cell proliferation, 2011-04, Vol.44 (s1), p.9-14

2011

Volltextzugriff (PDF)

Effect of severity of sepsis on tissue concentrations of linezolid

Journal of antimicrobial chemotherapy, 2008-01, Vol.61 (1), p.173-176

2008

Volltextzugriff (PDF)

447 Extended Analysis for Cancer Treatment (EXACT): Interim analysis of a prospective precision medicine trial

European journal of cancer (1990), 2015-09, Vol.51, p.S94-S94

2015

Volltextzugriff (PDF)

Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002

British journal of dermatology (1951), 2009-05, Vol.160 (5), p.955-964

2009

Volltextzugriff (PDF)

CCI-779 plus Cisplatin Is Highly Effective against Human Melanoma in a SCID Mouse Xenotranplantation Model

Pharmacology, 2007-01, Vol.79 (4), p.207-213

2007

Volltextzugriff (PDF)

Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells

British journal of cancer, 2003-10, Vol.89 (7), p.1352-1357

2003

Volltextzugriff (PDF)

Thalidomide Enhances the Anti-Tumor Activity of Standard Chemotherapy in a Human Melanoma Xenotransplatation Model

Journal of general internal medicine : JGIM, 2005-08, Vol.125 (2), p.201-206

2005

Volltextzugriff (PDF)

A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture

The New England journal of medicine, 2008-06, Vol.358 (24), p.2573-2584

2008

Volltextzugriff (PDF)

The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients

International journal of clinical pharmacology and therapeutics, 2005-12, Vol.43 (12), p.551-557

2005

Volltextzugriff (PDF)

Abscopal effect in the treatment of malignant melanoma

Hautarzt, 2015-07, Vol.66 (7), p.545-548

2015

Volltextzugriff (PDF)

Equipment availability and diagnostic strategies for suspected pulmonary embolism in Austria

European radiology, 2001-01, Vol.11 (11), p.2287-2294

2001

Volltextzugriff (PDF)

Abstract P5-21-23: Evaluation of the drug interaction potential of palbociclib and exemestane – Results from the PEARL pharmacokinetic sub-Study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-21-23

2018

Volltextzugriff (PDF)

The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis

Oncogene, 2003-10, Vol.22 (43), p.6725-6738

2003

Volltextzugriff (PDF)

Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice

Hepatology (Baltimore, Md.), 2002-11, Vol.36 (5), p.1106-1114

2002

Volltextzugriff (PDF)

Mcl-1 Antisense Therapy Chemosensitizes Human Melanoma in a SCID Mouse Xenotransplantation Model

Journal of investigative dermatology, 2003-06, Vol.120 (6), p.1081-1086

2003

Volltextzugriff (PDF)

Mcl-1 is a novel therapeutic target for human sarcoma: Synergistic inhibition of human sarcoma xenotransplants by a combination of Mcl-1 antisense oligonucleotides with low-dose cyclophosphamide

Clinical cancer research, 2004-06, Vol.10 (12), p.4185-4191

2004

Volltextzugriff (PDF)

The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells

Journal of investigative dermatology, 2005-06, Vol.124 (6), p.1293-1299

2005

Volltextzugriff (PDF)

Abscopal-Effekt in der Therapie des malignen Melanoms

Hautarzt, 2015-07, Vol.66 (7), p.545-548

2015

Volltextzugriff (PDF)

Clusterin Regulates Drug-Resistance in Melanoma Cells

Journal of investigative dermatology, 2005-06, Vol.124 (6), p.1300-1307

2005

Volltextzugriff (PDF)

Mcl-1 Blocks Radiation-induced Apoptosis and Inhibits Clonogenic Cell Death

Anticancer research, 2005-07, Vol.25 (4), p.2697-2703

2005

Volltextzugriff (PDF)

Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

International journal of cancer, 2002-05, Vol.99 (1), p.29-34

2002

Volltextzugriff (PDF)

Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight‐melanoma associated antigen (HMW‐MAA) specific monoclonal antibody

International journal of cancer, 2005-04, Vol.114 (3), p.426-432

2005

Volltextzugriff (PDF)

Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes

Melanoma research, 2003-10, Vol.13 (5), p.483-492

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL

Port-a-Cath® extravasation of vesicant cytotoxics: Surgical options for a rare complication of cancer chemotherapy

New perspectives in stem cell research: beyond embryonic stem cells

Effect of severity of sepsis on tissue concentrations of linezolid

447 Extended Analysis for Cancer Treatment (EXACT): Interim analysis of a prospective precision medicine trial

Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002

CCI-779 plus Cisplatin Is Highly Effective against Human Melanoma in a SCID Mouse Xenotranplantation Model

Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells

Thalidomide Enhances the Anti-Tumor Activity of Standard Chemotherapy in a Human Melanoma Xenotransplatation Model

A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture

The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients

Abscopal effect in the treatment of malignant melanoma

Equipment availability and diagnostic strategies for suspected pulmonary embolism in Austria

Abstract P5-21-23: Evaluation of the drug interaction potential of palbociclib and exemestane – Results from the PEARL pharmacokinetic sub-Study

The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis

Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice

Mcl-1 Antisense Therapy Chemosensitizes Human Melanoma in a SCID Mouse Xenotransplantation Model

Mcl-1 is a novel therapeutic target for human sarcoma: Synergistic inhibition of human sarcoma xenotransplants by a combination of Mcl-1 antisense oligonucleotides with low-dose cyclophosphamide

The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells

Abscopal-Effekt in der Therapie des malignen Melanoms

Clusterin Regulates Drug-Resistance in Melanoma Cells

Mcl-1 Blocks Radiation-induced Apoptosis and Inhibits Clonogenic Cell Death

Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight‐melanoma associated antigen (HMW‐MAA) specific monoclonal antibody

Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes

Suchergebnisse filtern